Efficacy and Safety Study of Ozanimod in Ulcerative Colitis

Completed · Phase 2 · Has a placebo group

Conditions studied: Ulcerative Colitis

In brief

The purpose of this study is to determine whether RPC1063 is effective in the treatment of ulcerative colitis (UC).

Key facts

Study ID
NCT01647516
Run by
Celgene
People needed
199
Starts
2012-12-26
Expected to finish
2019-08-30
Last updated by the study team
2021-05-19

Who can join

Age: 18 and older, up to 73. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.